BSECompany Update1d ago · 7 Aug 2026, 07:06 pm

Revised outcome

Omkar Speciality Chemicals Ltd · 533317

✦ AI SummaryResults

Omkar Speciality Chemicals Ltd has announced revised outcome after its board meeting held on June 12, 2026. The company approved the constitution of Nomination and Remuneration Committee and changed its registered office address. The board also approved the revised audited financial statements for the quarter and financial year ended March 31, 2026. The auditor's report noted that the financial statements give a true and fair view of the company's state of affairs and its loss, cash flows, and changes in equity for the year ended March 31, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Omkar Speciality Chemicals Ltd - 533317 - Board Meeting Outcome for Revised Outcome

Attachments (1)

📄

61d39bb9-dbcc-49ca-8d25-4aa0c47af014.pdf

pdf

Download →
View document text
@ OMKAR SPECIALITY CHEMICALS LIMITED Registered Office:- Mahalasa Narayani, Ganesh Chowk, Manjarli, Badlapur (East), Tha— n421e503 , Maharashtra CIN: L24110MH2005PLC151589 OMKREF Email:- omkar@kshitijpolyline.co.in Web:- www.omkarchemcicals.com Mobile:- +91 90818 72449 Always the leaders August 07", 2026 To, To, The Listing Department, The Listing Department, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Dalai Exchange Plaza, C-1, Block - G, Bandra Kurla Street, Mumbai - 400 001 Complex, Bandra (East), Mumbai - 400 051 Serip Code: 533317 NSE Symbol: OMKARCHEM Scrip Name: OMKARCHEM Sub: Outcome of Board Meeting held on June 12, 2026 under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the “Listing Regulations”). Dear Sir / Madam, Pursuant to the provisions of Regulation 30 (read with Part A of Schedule III) and Regulation 33 and Schedule 111, Part A, Para A (1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its meeting held today, i.e., on Friday, June, 12, 2026 inter-alia considered and approved the following: 1. Standalone Audited Financial Statements of the Company for the quarter and financial year ended March 31, 2026. A copy of the same in enclosed herewith. 2. The Board approved constitution of Nomination and Remuneration Committee. Name Designation Mr. Bhupeshkumar Jain Independent Dire— cChtairoperrso n Mr. Ruhini Kumar Chakraborty Independent Director —Member Ms. Muskaan Pherwani Independent Director —Member 3. The Board has approved the change of the registered office address within the local limits of the same city/town/village. The Board Meeting commenced at 04:00 p.m. and concluded at 07:35 p.m. @ OMKAR SPECIALITY CHEMICALS LIMITED Registered Office:- Mahalasa Narayani, Ganesh Chowk, Manjarli, Badlapur (East), Thane — 421503, Maharashtra CIN: L24110MH2005PLC151589 OMKREF Email:- omkar @kshitijpolyline.co.in Web:- www.omkarchemcicals.com Mobile:- +91 90818 72449 Always the leaders The aforementioned information is also being made available on the Company's website at www.omkarchemicals.com We request you to kindly take the above on record. For Omkar Speciality Chemicals Limited MAHENDRA s s KUMAR JAIN 255 Mahendra Kumar Jain Chairman & Director DIN: 09765526 Encl: as above ' RR. TIBREWALA & CO. CHARTERED ACCOUNTANTS Mumbai: 503, Atlanta Estate, G.M. Link Road, Goregaon- East, Mumbai- 400063 Ahmedabad: 701, Surmount Tower, Near Iscon Mega Mall, S.G. Highway, Ahmedabad- 380015 Email: rrtco75mumbai@gmail.com Tel. No.: +91 9867689583 INDEPENDENT AUDITOR'S REPORT To the Members of OMKAR SPECIALITY CHEMICALS LIMITED, Report on the Audit of the Financial Statements Opinion We have audited the Financial Statements of Omkar Speciality Chemicals Limited (‘the Company”), which comprise the Balance Sheet as at March 31, 2026, the Statement of Profit and Loss, the Cash Flow Statement and the Statement of Changes in Equity for the year then ended, and notes to the Financial Statements, including a summary of significant accounting policies and other explanatory information (hereinafter referred to as the “Financial Statements”). In our opinion and to the best of our information and according to the explanations given to us, the aforesaid Financial Statements give the information required by the Companies Act, 2013, as amended (‘the Act) in the manner so required and give a true and fair view in conformity with the accounting principles generally accepted inIndia, including the Indian Accounting Standards (“Ind AS”) specified under Section 133 of the Act, of the state of affairs of the Company as at March 31, 2026, and its loss, its cash flows and the changes in equity for the year ended on that date. Basis for Opinion We conducted our audit of the Financial Statements in accordance with the Standards on Auditing (SAs) specified under section 143(10) of the Act. Our responsibilities under those Standards are further described in the “Auditor's Responsibilities for the Audit of the Financial Statements” section of our report. We are independent of the Company in accordance with the ‘Code of Ethics’ issued by the Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the Financial Statements under the provisions of the Act and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion on the Financial Statements. Emphasis of Matter We draw attention to Note 4 to the Financial Statements, which describes that the Resolution Plan submitted by Khitij Polyline Limited (“Resolution Applicant”) under the Corporate Insolvency Resolution Process (“CIRP”) of the Company was approved by the Hon’ble National Company Law Tribunal (“NCLT"), Mumbai Bench, vide its order dated 31 July 2025. Pursuant to such approval, effect has been given to the Resolution Plan in these Financial Statements, including restatement of certain assets and liabilities as at the implementation date, as more fully explained in the aforesaid note. Our opinion is not modified in respect of this matter. We further draw attention to Note 5 to the Financial Statements regarding the basis on which the Financial Statements have been prepared on a going concern basis, as explained therein. Our opinion is not modified in respect of this matter. Other Matter The Financial Statements of the Company for the year ended March 31, 2025 were audited by the predecessor auditor, Satya Prakash Natani & Co., Chartered Accountants, who expressed an unmodified opinion with an emphasis of matter on those Financial Statements vide their report dated 30 July 2025. Our opinion is not modified in respect of this matter. Key Audit Matters Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the Financial Statements for the year ended March 31, 2026. These matters were addressed in the context of our audit of the Financial Statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters. Implementation of the Resolution Plan and Restatement of Assets and Liabilities As described in Note 4 to the Financial Statements, the Resolution Plan approved by the NCLT on 31 July 2025 was implemented during the year, resulting in significant restatement of borrowings, trade payables, provisions and other liabilities, and a corresponding impact on Other Equity. The implementation of the Resolution Plan involved significant management judgment in determining the appropriate accounting treatment and the amounts to be recorded, including the extinguishment and reissuance of equity shares and recognition of funds infused by the Resolution Applicant. We considered this to be a key audit matter due to the significance of the amounts involved and the degree of judgment applied by management. Our audit procedures, among others, included: reading the Resolution Plan approved by the NCLT and the order dated 31 July 2025; evaluating management's assessment of the accounting treatment adopted for giving effect to the Resolution Plan, including derecognition and recognition of liabilities and the consequential impact on equity; verifying the funds infused by the Resolution Applicant with bank statements and supporting documentation; and assessing the adequacy of related disclosures in Note 4 and Note 11 to the Financial Statements. Other Information The Company's Board of Directors is responsible for the other information. The other information comprises the information included in the Board’s Report of the Company, b [Showing first 8,000 characters — download PDF for full document]